د. نفيسة الرفاعي
د. نفيسة الرفاعي
أستاذ مشارك، رئيس قِسْم الهَنْدسة الصّيدلانيّة والكيميائيّة
مكتب: Building M, M-417
:هاتف +962 6 4294444 Ext. 4421
سيرة شخصية
Web of Science: https://www.webofscience.com/wos/author/record/AAW-8832-2021
Scopus: https://www.scopus.com/authid/detail.uri?authorId=57504545900
ORCID ID: https://orcid.org/0000-0003-3128-052X
Dr. Al-Rifai graduated from the University of Jordan, Jordan, with a B. Sc. degree in chemistry in 2004 (Excellent). After that, she obtained
an M. Sc. degree in Organic Chemistry (Excellent) from the same university in 2007 under the supervision of Prof. Dr. Musa Nazer. From 2007–2010, Al-Rifai worked as a teaching and research assistant at the Pharmaceutical-chemical engineering department at the German-Jordanian University.
In 2010, she was awarded a DAAD scholarship to do her PhD in Germany. She worked under the supervision of Dr. Sabine Amslinger at the University of Regensburg, Germany. Her work involved the synthesis and biological evaluation of α-substituted chalcones. After receiving her PhD degree in 2014, Al-Rifai joined the pharmaceutical and chemical engineering department, German- Jordanian University, Jordan as an assistant professor. Her research interests are in the field of organic synthesis and Medicinal chemistry.
الخلفية التعليمية
دكتوراه في الكيمياء الحيوية والطبية
MSc in Organic Chemistry, University of Jordan, Amman
BSc in Chemistry, University of Jordan, Amman
MSc in Organic Chemistry, University of Jordan, Amman
BSc in Chemistry, University of Jordan, Amman
الاهتمامات البحثية
Organic synthesis and Medicinal chemistry.
منشورات مختارة
| 2025 | Nafisah Al-Rifai,"Novel diazepine-carbamate derivatives as dual-acting butyrylcholinesterase inhibitors and antioxidants for Alzheimer’s disease",Medicinal Chemistry Research ,2025 [View] |
| 2025 | Nafisah Al-Rifai, Rayanah Amro, Jalal A. Zahra, Fouad Darras , Mutasem O. Taha ,"Novel diazepine-carbamate derivatives as dual-acting butyrylcholinesterase inhibitors and antioxidants for Alzheimer’s disease",Medicinal Chemistry Research ,2025 [View] |
| 2025 | Hadeel Alhourani, Nafisah Al-Rifai, Anas Alshishani,,"Development and Validation of a Stability-Indicating RP-HPLC Method for Bexagliflozin and Structural Elucidation of a Novel Acidic Degradation Product",MDPI,2025 [View] |
| 2023 | Nafisah Al-Rifai, Anas Alshishani, Fouad Darras, Ola Taha, Shereen Abu-Jalloud, Lena Shaghlil, Yousef Al-Ebini,"Synthesis, characterization, and analytical method (UPLC-UV) validation",2023 [View] |
| 2023 | Anas J. Rasras, Rawhi H. Al-Far, Eyad A. Younes, Mohamad M. Shakdofa, Nafisah M. Al-Rifai,"Synthesis and crystal structure, Hirshfeld surface analysis, and DFT calculation of 2-((4-(1-benzyl-2-methyl-4-nitro-1H-imidazol-5-yl)piperazin-1-yl)methyl)-5-phenyl-1,3,4-oxadiazole",Journal of Molecular Structure,2023 |
| 2021 | Nafisah M. Al-Rifai, Mohammad S. Mubarak,"α-Substituted Chalcones: A Key Review",ChemistrySelect (Wiley),6(46), 13224-13252,2021 [View] |
| 2020 | Ahmad Barghash, Samer I Al-Gharabli, Malak Jweihan, Maisam Tanbouz, Esra' AlBarahmieh, Eyad Hamad, Nafisah Al-Rifai, Hussam AlHawari, Lubna H Tahtamouni,"Angiotensin Converting Enzyme (ACE) Gene Polymorphism in Jordanian Type-1 and Type-2 Diabetic Patients",Jordan Journal of Biological Sciences,,13 (2),2020 |
| 2019 | Ziad Abu El-Rub, Joanna Kujawa, Esra’a Albarahmiah, Nafisah Rifai, Fathieh Qaimari, Samer Al-Gharabli,"High Throughput Screening and Characterization Methods of Jordanian Oil Shale as a Case Study",Energies 2019,12(16), 3148, doi,2019 [View] |
| 2015 | Rücker, H, Al-Rifai, N, Rascle, A, Gottfried, E, Brodziak-Jarosz, L, Gerhauser, C, Dick, T, & Amslinger, S ," Enhancing the anti-inflammatory activity of chalcones by tuning the Michael acceptor site ",Organic & Biomolecular Chemistry, 3.49 Impact Factor ,2015 |
| 2015 | Kaufmann KB, Al-Rifai N, Ulbrich F, Schallner N, Rücker H, Enzinger M, Petkes H, Pitzl S, Goebel U, Amslinger S," The Cytoprotective Effects of E-α-(4-Methoxyphenyl)-2',3,4,4'-Tetramethoxychalcone (E-α-p-OMe-C6H4-TMC)--A Novel and Non-Cytotoxic HO-1 Inducer",PLoS One,2015 Nov 13;10(11):e0142932. doi: 10.1371/journal.pone.0142932. PMID: 26565402; PMCID: PMC4643879.,2015 |
| 2014 | Pinz, S, Unser, S, Brueggemann, S, Besl, E, Al-Rifai, N, Hermina Petkes, & Amslinger, S," The Synthetic α-Bromo-2′,3,4,4′-Tetramethoxychalcone (α-Br-TMC) Inhibits the JAK/STAT Signaling Pathway ",PLoS ONE,9(3):e90275. 3.53 Impact Factor ,2014 |
| 2013 | Al-Rifai, N, Rücker, H, & Amslinger, S," Opening or Closing the Lock? When Reactivity Is the Key to Biological Activity",Chemistry - A European Journal ,19(45):15384–15395. 5.93 Impact Factor ,2013 |
| 2012 | Amslinger, S, Al-Rifai, N, Winter, K, Wörmann, K, Scholz, R, Baumeister, P, & Wild, M," Reactivity assessment of chalcones by a kinetic thiol assay",Organic & Biomolecular Chemistry,3.49 Impact Factor ,2012 |